IL27 and neoplasm: After staining for IL-30, we applied the evaluation criteria previously described in ref. [6], and selected PC samples with or without IL-30 expression, in both tumor cells and infiltrating leukocytes (ILK) (IL-30PosPC; n.25, and IL-30NegPC; n.59, respectively).